The global pet longevity therapeutics market is gaining momentum as pet owners increasingly prioritize preventive healthcare, healthy aging, and longer healthspans for companion animals. Growing pet humanization, advances in geroscience, and rising awareness of age-related conditions are encouraging demand for supplements and therapeutic foods designed specifically around the biology of aging. According to Grand View Research, the market was valued at USD 577.6 million in 2025 and is estimated to reach USD 621.6 million in 2026, before expanding to USD 1,145.9 million by 2033 at a CAGR of 9.13% from 2026 to 2033.

The industry is moving beyond conventional disease management toward proactive healthspan management. Advances in companion animal geroscience have increased interest in biological mechanisms associated with aging, including mitochondrial dysfunction, NAD+ depletion, cellular senescence, and metabolic changes. These developments are encouraging companies to develop products that support long-term functional health in aging pets.

Download a free sample copy of the Pet Longevity Therapeutics Market report to understand detailed coverage and inclusions in the final report

Key Market Competitors & Approaches

The commercial landscape includes established pet healthcare and nutrition companies as well as specialized brands developing products focused on healthy aging and longevity: 

• Leap Years: Focuses on longevity-oriented nutritional supplementation for companion animals, targeting biological mechanisms associated with aging.

• RENUE BY SCIENCE, Inc.: Develops formulations centered on cellular health and longevity-related ingredients, including NAD+-supporting compounds.

• PurePet: Participates in the pet wellness market with products designed to support the nutritional and health requirements of companion animals.

• Thorne Vet.: Combines veterinary health expertise with nutritional supplementation, addressing specific wellness and aging-related requirements in pets.

• Nestlé S.A. and Hill’s Pet Nutrition: Large established players benefit from extensive pet nutrition portfolios, veterinary relationships, research capabilities, and broad distribution networks.

• Nutramax Laboratories and Zesty Paws: Focus on supplements and functional pet-health products addressing specific nutritional and wellness needs.

The competitive environment is increasingly influenced by scientific substantiation, specialized formulations, veterinary recommendations, and the expansion of direct-to-consumer and e-commerce distribution channels. 

Emerging Treatment Modalities

The market is broadly developing around nutritional supplementation, therapeutic foods, and emerging longevity-focused approaches designed to address the biological processes associated with aging:

1. Advanced Supplements: Supplements accounted for 68.7% of global market revenue in 2025, making them the dominant product category. Growing consumer awareness of cellular aging and preventive pet healthcare is encouraging demand for formulations containing longevity-oriented ingredients and nutritional compounds. 

2. Therapeutic Foods: Therapeutic foods represent another important product category, particularly for senior animals requiring nutritional support for metabolic, cognitive, renal, and other age-associated health requirements. Manufacturers are increasingly developing specialized diets that combine nutritional management with broader healthy-aging objectives.

3. Cellular Energy and Metabolic Resilience: This indication is expected to register the fastest CAGR during the forecast period. Increasing interest in NAD+ boosters, NMN/NR-based ingredients, and mitochondrial-support formulations is encouraging product innovation focused on cellular energy and metabolic function. 

4. Cognitive Aging and Neuroprotection: Cognitive aging and neuroprotection represented the largest indication segment in 2025. Growing awareness of age-related cognitive changes in companion animals is supporting demand for products designed to maintain cognitive and neurological function during later life stages. 

Looking for more specific insights? Customize this report to suite your business needs

Pipeline Structure & Geographic Trends

• North American Dominance: North America accounted for 39.3% of global revenue in 2025, making it the largest regional market. The region benefits from established veterinary infrastructure, high pet healthcare expenditure, strong consumer awareness, and the presence of numerous pet-health companies and specialized longevity brands.

• Canine Focus: The canine segment accounted for the largest revenue share in 2025 and is anticipated to register the fastest CAGR during the forecast period. Greater availability of dog-specific products and extensive research into canine aging are contributing to segment expansion. 

• E-commerce Expansion: E-commerce accounted for the largest distribution-channel revenue share in 2025 and is projected to register the fastest CAGR during the forecast period. Online channels provide manufacturers with direct access to pet owners while enabling subscription-based purchasing, product education, and broader geographic reach. 

• Asia Pacific Growth: Asia Pacific is expected to record the fastest CAGR of 10.2% from 2026 to 2033. Increasing pet ownership, improving disposable incomes, growing awareness of premium pet healthcare, and rising expenditure on companion-animal wellness are creating new opportunities across the region. 

• Research and Product Development: Companies are increasingly concentrating on formulations that address cellular aging, metabolic resilience, cognitive health, and other biological processes associated with aging. The combination of veterinary research and consumer interest in longevity is encouraging the development of more specialized products.

Current Market Barriers

Despite strong consumer interest, the pet longevity therapeutics market faces several challenges. One of the major barriers is the need for stronger clinical evidence supporting longevity-related claims. Many products are positioned around healthy aging and wellness rather than proven lifespan extension, making scientific validation an important factor in establishing consumer and veterinary confidence.

Regulatory differences between nutritional supplements, therapeutic foods, and veterinary pharmaceuticals also create complexity for manufacturers. Companies must carefully manage product claims, safety requirements, ingredient standards, and market-specific regulations.

Another challenge is the comparatively high cost associated with research, product development, clinical validation, and commercialization. In addition, the market remains more developed for dogs than cats, creating a need for greater research into feline-specific aging mechanisms and formulations.